inclisiran Search Results


93
MedChemExpress inclisiran
Inclisiran, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inclisiran/product/MedChemExpress
Average 93 stars, based on 1 article reviews
inclisiran - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Novartis pcsk9 nucleic acid inhibitor inclisiran
Pcsk9 Nucleic Acid Inhibitor Inclisiran, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcsk9 nucleic acid inhibitor inclisiran/product/Novartis
Average 90 stars, based on 1 article reviews
pcsk9 nucleic acid inhibitor inclisiran - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Novartis orion 4 trial of inclisiran
Orion 4 Trial Of Inclisiran, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/orion 4 trial of inclisiran/product/Novartis
Average 90 stars, based on 1 article reviews
orion 4 trial of inclisiran - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Novartis leqvio (inclisiran)
Leqvio (Inclisiran), supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/leqvio (inclisiran)/product/Novartis
Average 90 stars, based on 1 article reviews
leqvio (inclisiran) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Novartis inclisiran
Inclisiran, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inclisiran/product/Novartis
Average 90 stars, based on 1 article reviews
inclisiran - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
The Medicines Company inclisiran
Inclisiran, supplied by The Medicines Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inclisiran/product/The Medicines Company
Average 90 stars, based on 1 article reviews
inclisiran - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Alnylam Inc inclisiran leqviotm
Inclisiran Leqviotm, supplied by Alnylam Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inclisiran leqviotm/product/Alnylam Inc
Average 90 stars, based on 1 article reviews
inclisiran leqviotm - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd inclisiran
Inclisiran, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inclisiran/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
inclisiran - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Sirna Therapeutics silencing rna (sirna) agent inclisiran
Silencing Rna (Sirna) Agent Inclisiran, supplied by Sirna Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/silencing rna (sirna) agent inclisiran/product/Sirna Therapeutics
Average 90 stars, based on 1 article reviews
silencing rna (sirna) agent inclisiran - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Alnylam Inc drug inclisiran
Six Approved siRNA Therapeutics <xref ref-type= a " width="250" height="auto" />
Drug Inclisiran, supplied by Alnylam Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/drug inclisiran/product/Alnylam Inc
Average 90 stars, based on 1 article reviews
drug inclisiran - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Novartis sirna lipid-lowering drug inclisiran
Mechanism of action of <t>Inclisiran.</t> GalNAc tail, N-acetylgalactosamine tail; RISC, RNA-induced silencing complex; PCSK9, Proprotein convertase subtilisin/kexin type 9.
Sirna Lipid Lowering Drug Inclisiran, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirna lipid-lowering drug inclisiran/product/Novartis
Average 90 stars, based on 1 article reviews
sirna lipid-lowering drug inclisiran - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Novartis rna interference therapies inclisiran
Major <t> inclisiran </t> trials LDL-C: Low-density lipoprotein cholesterol
Rna Interference Therapies Inclisiran, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rna interference therapies inclisiran/product/Novartis
Average 90 stars, based on 1 article reviews
rna interference therapies inclisiran - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Six Approved siRNA Therapeutics <xref ref-type= a " width="100%" height="100%">

Journal: Journal of Medicinal Chemistry

Article Title: Metabolic Stability and Targeted Delivery of Oligonucleotides: Advancing RNA Therapeutics Beyond The Liver

doi: 10.1021/acs.jmedchem.4c02528

Figure Lengend Snippet: Six Approved siRNA Therapeutics a

Article Snippet: An example is the FDA-approved drug inclisiran, which was discovered by Alnylam and developed by Novartis to treat hypercholesterolemia.

Techniques: Formulation, Injection

Mechanism of action of Inclisiran. GalNAc tail, N-acetylgalactosamine tail; RISC, RNA-induced silencing complex; PCSK9, Proprotein convertase subtilisin/kexin type 9.

Journal: Frontiers in Pharmacology

Article Title: Inclisiran: a new generation of lipid-lowering siRNA therapeutic

doi: 10.3389/fphar.2023.1260921

Figure Lengend Snippet: Mechanism of action of Inclisiran. GalNAc tail, N-acetylgalactosamine tail; RISC, RNA-induced silencing complex; PCSK9, Proprotein convertase subtilisin/kexin type 9.

Article Snippet: On July 2 2021, Novartis Pharmaceuticals held a press conference to announce that its new siRNA lipid-lowering drug, Inclisiran, had completed the first injection in China in Boao Super Hospital.

Techniques:

Characteristics and outcomes of the clinical trials of  Inclisiran  for hypercholesterolemia.

Journal: Frontiers in Pharmacology

Article Title: Inclisiran: a new generation of lipid-lowering siRNA therapeutic

doi: 10.3389/fphar.2023.1260921

Figure Lengend Snippet: Characteristics and outcomes of the clinical trials of Inclisiran for hypercholesterolemia.

Article Snippet: On July 2 2021, Novartis Pharmaceuticals held a press conference to announce that its new siRNA lipid-lowering drug, Inclisiran, had completed the first injection in China in Boao Super Hospital.

Techniques: Clinical Proteomics, Biomarker Discovery

The development and use of Inclisiran in China: a chronological overview.

Journal: Frontiers in Pharmacology

Article Title: Inclisiran: a new generation of lipid-lowering siRNA therapeutic

doi: 10.3389/fphar.2023.1260921

Figure Lengend Snippet: The development and use of Inclisiran in China: a chronological overview.

Article Snippet: On July 2 2021, Novartis Pharmaceuticals held a press conference to announce that its new siRNA lipid-lowering drug, Inclisiran, had completed the first injection in China in Boao Super Hospital.

Techniques:

Status quo, prospects and challenges of Inclisiran.

Journal: Frontiers in Pharmacology

Article Title: Inclisiran: a new generation of lipid-lowering siRNA therapeutic

doi: 10.3389/fphar.2023.1260921

Figure Lengend Snippet: Status quo, prospects and challenges of Inclisiran.

Article Snippet: On July 2 2021, Novartis Pharmaceuticals held a press conference to announce that its new siRNA lipid-lowering drug, Inclisiran, had completed the first injection in China in Boao Super Hospital.

Techniques:

Major  inclisiran  trials LDL-C: Low-density lipoprotein cholesterol

Journal: Cureus

Article Title: New Insights Into the Treatment of Hyperlipidemia: Pharmacological Updates and Emerging Treatments

doi: 10.7759/cureus.63078

Figure Lengend Snippet: Major inclisiran trials LDL-C: Low-density lipoprotein cholesterol

Article Snippet: RNA interference (RNAi) therapies Inclisiran Inclisiran, also known as Leqvio and manufactured by Novartis, is a novel subcutaneously used lipid-lowering agent that utilizes RNA interference technology to reduce LDL-C levels.

Techniques: